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Background: Developing brain is highly susceptible to hypoxic-ischemic injury leading to severe neurological
disabilities in surviving infants and children. Previously we reported induction of neuronal pentraxin 1 (NP1) in
hypoxic-ischemic injury in neonatal brain and NP1 co-localization with the excitatory AMPA receptors GluR1 at the
synaptic sites. However, how NP1 contributes to hypoxic-ischemic neuronal injury is not completely understood.
Results: Here we report that extracellular secretion of NP1 is required for ischemic neuronal death. Primary cortical
neurons at days in vitro (DIV) 12 were subjected to oxygen glucose deprivation (OGD), an in vitro model of
ischemic stroke, for different time periods (2 ? 8 h). Oxygen glucose deprivation showed characteristic morphological
changes of dying cells, OGD time-dependent induction of NP1 (2-4-fold) and increased neuronal death. In contrast,
the NP1-KO cortical neurons were healthy and showed no sign of dying cells under similar conditions. NP1gene
silencing by NP1-specific small interfering RNA (NP1-siRNA) protected cortical neurons from OGD-induced death.
Conditioned media (CM) collected from OGD exposed WT cortical cultures caused neurotoxicity when added to a subset
of DIV 12 normoxia control WT cortical cultures. In contrast, CM from OGD-exposed NP1-KO cultures did not induce cell
toxicity in control WT cultures, suggesting a role for extracellular NP1 in neuronal death. However, NP1-KO neurons, which
showed normal neuronal morphology and protection against OGD, sustained enhanced death following incubation with
CM from WT OGD-exposed cultures. Western blot analysis of OGD exposed WT CM showed temporal increase of NP1
protein levels in the CM. Most strikingly, in contrast to NP1-KO CM, incubation of normal cortical cultures with CM from
OGD exposed NP2-KO cultures showed neurotoxicity similar to that observed with CM from OGD exposed WT neuronal
cultures. Western immunoblotting further confirmed the increased presence of NP1 protein in OGD-exposed NP2-KO CM.
Live immunofluorescence analysis show intense cell surface clustering of NP1 with AMPA GluR1 receptors.
Conclusions: Collectively, our results demonstrate that extracellular release of NP1 promote hypoxic-ischemic neuronal
death possibly via surface clustering with GluR1 at synaptic sites and that NP1, not its family member NP2, is involved in
the neuronal death mechanisms.
Keywords: Oxygen glucose deprivation, Neuronal pentraxin 1, Conditioned medium, Neuronal death, Primary cortical
neurons, Synapse, AMPA receptor GluR1Background
Neuronal injury occurring with cerebral hypoxia-ischemia
(HI) has been attributed to overstimulation of N-methyl-
D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-
4-isoxazole-propionic acid (AMPA) subtypes of glutamate
receptors [1-4], oxidative stress, and activation of intrinsic* Correspondence: hossain@kennedykrieger.org
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article, unless otherwise stated.program of apoptotic cell death [5]. One of the proteins
that is induced under hypoxic-ischemic stress and initiates
neuronal death program is ? neuronal pentraxin 1′ (NP1)
[6-8]. However, how NP1 contributes to neuronal death
is not completely understood. NP1 is predominantly
expressed in the central nervous system [9-12] and be-
longs to the ? long pentraxins ? family of proteins; NP1,
neuronal activity-regulated pentraxin (Narp; also called
NP2), and neuronal pentraxin receptor (NPR) [9,12,13].
Neuronal pentraxins have high homology among hu-
man, mouse and rats [14]. The pentraxins have several
structural and functional characteristics to form side-ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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[13,15,16] and the ability to bind other proteins via a
lectin-like domain.
Proposed functions of NPs include modulating synap-
tic uptake, synapse formation, and synaptic remodeling
[9,17]. NP2 has been reported to mediate synaptic clus-
tering of AMPA glutamate receptors [18,19]. In our pre-
vious studies, we have shown induction of NP1 in
neonatal mice brain following HI and injury to the cere-
bral cortex and hippocampal CA3 and CA1 brain re-
gions [7,20,21]. We found that the increase in NP1
induction occurs before the actual cell death, consistent
with a role for NP1 in the injury mechanisms. We also
found that NP1 co-localizes with AMAP GluR1 receptors
and enhanced GluR1 membrane insertion at the synaptic
sites as evident by NP1-GluR1-PSD-95 co-clustering fol-
lowing OGD exposure [22]. It is known that various cell
death mechanisms require de novo synthesis of both RNA
and lethal proteins [5,23], and low neuronal activity triggers
the intrinsic program of apoptotic cell death in mature neu-
rons [5]. However, how induction of NP1 expression leads
to the propagation of neuronal death or survival of neurons
in the absence of NP1 expression is not completely under-
stood. Here, we report that the extracellular secretion of
NP1 is required to induce neuronal death in primary cor-
tical neurons subjected to oxygen glucose deprivation
(OGD) possibly through co-clustering with APMA GluR1
receptors at synaptic sites and enhanced excitotoxicity. Our
findings suggest that blockade of NP1 induction and its
extracellular release may be therapeutically relevant against
hypoxic-ischemic injury in neonatal brain.
Methods
Embryonic cortical neuronal culture
The Johns Hopkins University Institutional Animal Care
and Use Committee approved all animal protocols used;
they complied with the US NIH Guide for the Care and
Use of Laboratory Animals. Primary cortical neuronal cul-
tures were prepared from embryonic day 16 (E16) wild-
type (WT) and NP1-knockout (NP1-KO) mice as described
previously [7]. NP1 knockout mice were provided by Dr.
Paul Worley, Dept. of Neuroscience, School of medicine,
Johns Hopkins University, Baltimore, MD, USA. Primary
cortical neurons were grown in a culture medium consist-
ing of Neurobasal? medium (Invitrogen, Carlsbad, CA,
USA), 2% B27 supplement (Invitrogen), 2-mM L-glutam-
ine, and 1% penicillin-streptomycin as described previously
[7]. At 3 days in vitro (DIV), one-third of the media was re-
placed with fresh medium (without L-glutamine) contain-
ing cytosine arabinofuranoside (AraC, 5 μM; Sigma, St.
Louis, MO, USA) to arrest the growth of non-neuronal
cells. Experiments were conducted at DIV 12, when cul-
tures consisted primarily of neurons (>95% MAP-2 immu-
noreactive cells) (MAP-2; Chemicon, Temecula, CA, USA).Induction of OGD, modeled in vitro, using cultured
primary cortical neurons
To induce oxygen glucose deprived conditions, cultured
cortical neurons at DIV 12 were exposed to OGD as de-
scribed previously [6,22,24]. Briefly, neurons were placed
in glucose-free Earl? s balanced salt solution (EBSS) and
then exposed to humidified 95% N2/5% CO2 using anaer-
obic modular incubator chambers (Billups-Rothenberg,
Del Mar, CA, USA) for different time periods (2? 8 h).
Control cultures were incubated with EBSS with glucose
and incubated in humidified 95% air/5% CO2 for the same
duration. After indicated periods of OGD, cells were
washed with ice-cold PBS and harvested to examine vari-
ous biochemical and morphological end points.
SDS-PAGE and western blot analyses
SDS-PAGE and immunoblotting were performed ac-
cording to the method as described previously [7,25,26].
Total proteins (20? 30 μg) were diluted in Laemmli buffer
containing 2-mercaptoethanol, heated to 95?C for 5 min,
separated on a 4-20% gradient Tris-glycine precast gel
(Invitrogen) at 120 V for 1.5 h. Blots were incubated with
primary antibodies specific for NP1 (1:500, BD Transduc-
tion Laboratories, Tamecula, CA, USA). HRP (horseradish
peroxidase)-conjugated secondary antibodies (GE Health-
care, Piscataway, NJ, USA) were used at 1:10000 dilutions
for 1 h at room temperature. The HRP reaction product
was visualized using an ECL Western blotting detection
kit (GE healthcare). Image films were scanned in gray scale
(HP Scanjet G4010) at a high resolution as TIFF files. Im-
munoreactive protein bands corresponding to the correct
molecular mass of target protein were quantified by draw-
ing rectangle around the individual band and the intensity
was measured by densitometry using NIH ImageJ soft-
ware. Values were normalized to internal standard actin,
which also serve as a loading control, to make relative
comparisons.Assessment of cell viability/toxicity
Immediately after the indicated periods of OGD exposure,
cell viability and cell death was determined by independ-
ent and complementary methods as described previously
[6,7,22,24].MTT assay
Mitochondrial dehydrogenase activity cleaves 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT; Sigma), which is considered as a biochemical index
for cellular viability. A quantitative colorimetric assay of
MTT [27] used to determine cell survival as described
previously [7,25]. The results were expressed as a percent-
age of control cultures viability.
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Lactate dehydrogenase (LDH) activity released in the media
after OGD exposure was measured using the CytoTox96
Non-radioactive Cytotoxicity Assay kit (Promega, Madison,
WI, USA) as described previously [7,28]. Percent cell death
was determined using the formula: % cytotoxicity =OGD-
induced LDH release (OD490)/maximum LDH release
(OD490) after correcting for baseline absorbance of LDH re-
lease at 490 nm.
TUNEL staining
The DeadEnd Fluorometric TUNEL System (Promega)
was used to detect cell death in cultured primary cortical
neurons exposed to OGD (2-8 h) as described previously
[29,30]. This method allows direct detection of nuclear
DNA fragmentation, an important biochemical hallmark
of cell death, by catalytically incorporating fluorescein-12-
dUTP at 3′-OH DNA ends. Primary cortical cultures
grown on cover slips were processed according to manu-
facturers? instructions. Negative controls were performed
under identical conditions except for the omission of ter-
minal deoxynucleotidyl transferase (TdT) from the reac-
tion buffer. Fluorescein fluorescence was visualized in a
fluorescence microscope (Carl Zeiss Axioplan 1) with an
excitation at 485 nm and an emission at 535 nm. DAPI
fluorescence (blue) was visualized with an excitation and
emission filters at 365 nm and 450 nm, respectively.
Short interference RNA (siRNA) directed against
NP1 mRNA
For NP1 gene silencing experiments, we have used Ntpx1
specific siRNA constructs (5′-AATTCTTCCAGCCAAA
CCAAC-3′) (construct #3) (5-AAGAACGACACAGAGG
AAAGG-3′) (construct #5) generated using Silencer?
siRNA construction kit (Cat #1620) (Ambion, Inc. Austin,
TX, USA) and the commercially available control
scramble siRNA (SsiRNA) following methods de-
scribed previously [8]. The oligodeoxyribonucleotide
sequences exhibited no similarity to any other known
mammalian genes as determined by BLAST. Experimental
treatments were initiated ~ 48 h after transfection. Using
siRNA specific for NP1, we have achieved >90% reduction
in NP1 protein levels compared to control SsiRNA.
Quantification of NP1 expression by real-time PCR
Total RNA was extracted from control and OGD-
exposed primary cortical cultures using TRIzol reagent
(Invitrogen) according to manufacturer ? s protocol. The
cDNA was synthesized from 1 μg of purified total RNA
using iScript ? cDNA Synthesis Kit (Bio-Rad laboratories,
Richmond, CA, USA), following the manufacturer ? s in-
structions. Quantitative real-time PCR was performed in
triplicate by using iQ SYBR Green Supermix on CFX96 ?
Real-Time System (Bio-Rad) as described previously [6].The mRNA level was normalized by housekeeping gene
HPRT [31]. The primers set used for NP1 (Acc. No.
NM_008730.2) were 5′-GCT GCG AGA GCC AGA
GCA CC-3′ (sense) and 5′-TTG CCC GAG TTG GCT
GAG CG-3′ (anti-sense), and for HPRT were 5′-CCT
GGC GTC GTG ATT AGT GAT G-3′ (sense) and 5′-C
AG AGG GCTACA ATG TGATGG C-3′ (anti-sense).
Immunofluorescence
Live double-immunofluorescence staining of primary
cortical cultures (DIV 12) with NP1 was done as de-
scribed previously [7,22]. Briefly, cortical neurons, grown
on coverslips, following exposure to OGD (4 h) were live
labeled with both anti-NP1 (1:100; BD Transduction La-
boratories) and anti-GluR1 (1:100; Millipore) by adding
directly to the medium and further incubated for 45 min
at 37?C. Neurons were then fixed with 3.7% formalde-
hyde, and permeabilized cells were stained with anti-
mouse Alexa Fluor 568 (red, NP1) and anti-rabbit Alexa
fluor 488 (green, GluR1)-conjugated secondary anti-
bodies (Invitrogen). Slides were coverslipped with prolong
mounting medium containing DAPI (blue) (Molecular
Probes, Eugene, OR, USA) to stain nuclei. Immunofluor-
escence was visualized using an inverted fluorescence
microscope (Olympus IX51fitted with DP2-DSW-V3.2 ap-
plication software) at 10 ? and ZEISS Axioimager M2
(AxioVision SE64 Rel.4.8.1 application software) at 100 ?
magnification.
Statistical analysis
Statistics were performed using GraphPad Prism software,
Version 5.01. For one experimental and one control group,
two-tailed Student? s t-test was used to determine if differ-
ences exist between means. Comparisons involving multiple
groups were done by ANOVA, followed by Bonferroni/
Dunn post-hoc test where appropriate. Significance level
was assigned at P < 0.05.
Results
Induction of NP1 in primary cortical neurons exposed to
oxygen glucose deprivation
Primary cortical neuronal cultures at DIV12 were exposed
to OGD for indicated times (2? 8 h). Control cultures were
incubated with EBSS containing glucose and exposed to
humidified 95% air/5% CO2 for the same duration of time.
Light microscopic analysis showed that control neurons
were healthy and retained normal morphology, as indi-
cated by larger size, phase brightness and intact processes.
Whereas, OGD exposed neurons showed characteristic
morphological changes of dying cells, which were round,
smaller and translucent with disintegration of processes
and cell bodies compared to control normoxic neurons
(Figure 1). In contrast, NP1-KO cortical cultures retained
normal neuronal morphology; intact processes and healthy










Figure 1 The OGD time-dependent progression of cytotoxicity in primary cortical neurons. Primary cortical cultures at DIV 12 were
submitted to OGD conditions for indicated time periods as described in the Methods. Light microscopic images show morphological evidence of
degenerated neurons and disintegration of processes (yellow arrow) of WT cortical neurons (upper panels) and healthy cell bodies with intact
processes of NP1-KO neurons (lower panels) observed following OGD exposure as compared to respective normoxia control neurons. Scale
bar, 100 μm.
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trol cultures (Figure 1). This in vitro OGD model was used
in subsequent experiments to determine the role of NP1
and its specific requirement for ischemic neuronal death.
Next, we asked if NP1 is induced in cultured primary
cortical neurons in response to OGD. The RT-qPCR
data showed OGD time-dependent increased expres-
sions of NP1 mRNA (~4-fold; p < 0.01) compared to that
in normoxia controls (Figure 2A). The increased expres-
sion of NP1 mRNA was further validated by Western
blot analyses (Figure 2B). Western blot analysis of total
cellular extracts revealed a NP1-specific immunoreactive
protein band with apparent molecular mass of ~47 kDa
consistent with the expected size of NP1 [9,17]. Quanti-
tative densitometry values of NP1 protein normalized to
β-actin (NP1/β-actin ratio, n = 6) further confirmed OGD
time-dependent increase of NP1 protein levels, which
reached the maximum (4-fold) at 8 h of OGD, examined.
The NP1 protein levels in normoxia controls were low but
detectable range.
OGD exposure caused cytotoxicity in WT neurons, whereas,
NP1-KO cortical neurons are protected against OGD
Primary cortical neuronal cultures at DIV 12 were exposed
to OGD for different time periods (4, 6, and 8 h). LDH re-
lease cytotoxicity assay revealed OGD time-dependent in-
crease in cell death in WT cortical cultures. OGD exposure
(4? 6 h) resulted 30-50% (p < 0.001) cell death in WT cul-
tures (Figure 2C). In contrast, we observed very negligiblechange (not significant) in the release of LDH in NP1-KO
neurons as compared to the WT cells following OGD ex-
posure. Interestingly, NP1-KO cortical neurons maintained
morphological integrity for, at least, 8 h of OGD exposure,
which were consistent with cell cytotoxicity as determined
by % LDH release (Figure 2D).
Specific involvement of NP1 in OGD-induced neuronal death
To determine the specificity of NP1 induction in neur-
onal death, we transfected WT primary cortical neurons
with either control scramble (SsiRNA) or NP1-siRNA to
knockdown NP1 in WT neurons (Figure 3). Using our
established protocol, we found that NP1-siRNA almost
completely knockdown NP1 protein levels (>90%) com-
pared to that in cells transfected with control SsiRNA
(shown in inset). Here, we asked that if the NP1 induction
is directly associated with neuronal death then knocking
down of NP1 protein will protect cortical neurons against
OGD-induced death. LDH cytotoxicity (Figure 3A), MTT
cell viability (Figure 3B) assays and TUNEL (+) staining
for degenerated neurons (Figure 3C) revealed that OGD
exposure (6 h) resulted significant cell death (p < 0.01) in
WT neurons transfected with control scramble siRNA. In
contrast, primary cortical neurons transfected with NP1-
siRNA, showed significantly decreased neurotoxicity and
degenerated neurons (i.e. neuroprotection) when submit-
ted to OGD exposure (6 h). Our results clearly demon-
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Figure 2 The NP1 induction is associated with OGD-induced cortical neuronal death. A) Total cellular RNA was extracted and NP1 mRNA
expression levels were analyzed by RT-qPCR. Data show relative quantification of Nptx1 expression at different time periods of OGD exposure.
Fold induction is the ratio of NP1 to internal control HPRT, which remained stable throughout the OGD period (mean ? SEM, n = 6; *p < 0.05,
**p < 0.01). B) Total cellular protein was analyzed by SDS-PAGE and immunoblotted for NP1 protein using NP1-specific antibody that detected
NP1-immunoreactive single band of molecular mass 47 kDa. The β-actin serves as loading control. Quantitative densitometry values normalized to
β-actin (NP1/β-actin ratio, n = 6) are also shown. Representative bands are shown. C & D) OGD exposure of WT cortical neurons caused cell death, while
NP1-KO neurons were protected against OGD. Quantification of cell death as indicated by LDH release showed OGD time dependent increase of LDH
release at 2, 4, 6, and 8 h of OGD exposures of WT cortical neurons. LDH release remained at the control level or non-significant increase in
OGD-exposed NP1-KO neurons. Data are expressed as % LDH release normalized to normoxia control (mean ? SEM, n = 8; *p < 0.05, ***p < 0.001). We
found ~ 50% cytotoxicity occurred at 6 h of OGD.
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(CM) from OGD-exposed WT primary cortical cultures
Because of the secretory nature of NP1 [9,11-13], we
asked if NP1 induction is associated with hypoxic-
ischemic neuronal death, then extracellularly secreted
NP1 might be also contributing to the neuronal death ob-
served. We collected the conditioned media (CM) from
control and OGD exposed WT cortical cultures (WT-
OGD CM) and concentrated using Microsep? 30K Omega
Centrifugal Devices (Cat no. OD030C46; Pall Life Sci-
ences, Ann Arbor, MI, USA). Western blot analysis of WT
control and OGD-exposed CM confirmed OGD time-
dependent increase of NP1 protein levels present in the
WT-OGD CM (Figure 4A). After confirming the presence
of NP1 in the WT-OGD CM, we added this CM to a sub-
set of control cortical cultures at DIV 12 and incubated
for additional 24 h. An additional group of the same
CM-treated cultures were also exposed to OGD (6 h).
LDH release cytotoxicity assay revealed that addition of
WT-OGD CM to control normoxia cultures resultedsignificant cell death (P < 0.01) similar to that observed
with OGD exposed WT cultures (Figure 4B). In
addition, OGD exposure of the WT-OGD CM treated
neurons further enhanced the cytotoxicity (p < 0.01)
(Figure 4B).
To specifically examine the role of NP1 in neuronal death,
we used CM collected separately from control, OGD-
exposed WT (WT-OGD CM) and NP1-KO cortical cultures
(NP1-KO OGD CM), concentrated as above, added to sep-
arate subsets of WT and NP1-KO cultures at DIV 12, and
incubated for additional for 24 h (Figure 5). Most interest-
ingly, we found that WT-OGD CM caused neuronal death
(degeneration of cell bodies and processes as shown by yel-
low arrows) when added to normal WT cultures (Figure 5
A1). In contrast, the CM from OGD exposed NP1-KO
(NP1-KO OGD CM) did not cause any degeneration of pro-
cesses and cell bodies and maintained normal neuronal
morphology (shown by green arrows) when added to the
normoxia WT cultures (Figure 5B1) similar to control cul-















































































































































Figure 3 Knockdown of NP1 by siRNA targeted against NP1 mRNA significantly protected against OGD-induced neuronal death. We
have achieved >90% reduction in NP1 protein compared to scramble siRNA (shown in inset). LDH cytotoxicity and MTT cell viability (A-B) showed
significantly less cell death in NP1-siRNA transfected WT cells vs. non-transfected cells following exposure to OGD (6 h). Data are expressed as
percent LDH release normalized to normoxia control (mean ? SEM, n = 8; **p < 0.01 compared to control normoxia; +p < 0.01compared to OGD
scramble siRNA group) C) TUNEL staining of cortical neurons transfected with either control scramble or NP1-siRNA revealed significant increase
in the number of TUNEL (+ve) cells in scramble SsiRNA transfected cultures, which was significantly reduced in NP1-siRNA transfected neurons.
Data are expressed as percent TUNEL/DAPI cells (mean ? SEM, n = 8; **p < 0.01 compared to control normoxia; +p < 0.01compared to OGD
scramble siRNA group).
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otherwise showed neuroprotection against OGD. Our find-
ings confirm the specific involvement of NP1 in neuronal
death and neuronal survival in the absence of NP1 protein
expression. Taken together, our results clearly demonstrate
the role of extracellular NP1 in ischemic neuronal death.
Presence of NP1 protein in the CM, but not the NP2, is
involved in OGD-induced neurotoxicity
To further validate the specificity of NP1 in neurotoxicity,
we added CM from OGD-exposed NP2-KO cultures
(NP2-KO OGD CM) to a subset of WT normal cortical
cultures. As we have observed in Figure 4B and 5A, the
LDH release cytotoxicity assay showed significantly in-
creased neurotoxicity (p < 0.01) when the NP2-KO OGDCM was added to normal WT cortical cultures (Figure 6
B), similar to that observed in case of WT-OGD CM
(Figure 6A). Western blot analysis of NP2-KO OGD CM
revealed increased levels of NP1 protein present in the CM
from OGD-exposed NP2-KO cortical cultures. Our results
clearly delineate the involvement of NP1, but not the NP2,
in ischemic neuronal death following OGD, suggesting the
specificity of NP1 in the neuronal injury mechanisms.
Surface clustering of extracellular NP1 with AMPA
GluR1 receptors
Previously we reported that OGD exposure promotes re-
distribution of AMPA GluR1 receptors at the postsynaptic
membrane and significantly increased the NP1-GluR1 in-
























































Figure 4 OGD-conditioned culture media caused increased neuronal death in cortical neuronal cultures. Primary cortical cultures at DIV
12 were exposed to OGD and conditioned media (CM) were collected, centrifuged and concentrated as described in the methods. A) Western
blot analysis of CM from OGD-exposed WT primary cortical cultures showed OGD time-dependent increase of NP1 protein levels. B) This CM of
OGD exposed WT cultures (WT-OGD CM) was added to a subset of control cortical cultures for 24 h (Control + WT-OGD CM). In addition, another
subgroup of cells was also exposed to 6 h of OGD (WT-OGD CM +OGD). Data shown are mean ? SEM (n = 8 in each group) and repeated two
times, **p < 0.01 vs. normoxia controls; +p < 0.01 vs. OGD only and Control + WT-OGD CM group.
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clustering with GluR1 under similar OGD conditions [22].
We asked if extracellular release of NP1 following OGD
interacts with GluR1. Live immunostaining with both NP1
and GluR1 antibodies showed intense increase of NP1-
GluR1 co-clustering in the dendrites and axons of the
OGD-exposed cortical neurons compared to the normoxia
controls (Figure 7). Our results suggest a relationship be-
tween extracellular release of NP1 following NP1 induc-
tion and synaptic clustering of GluR1, which in turn
promote OGD-induced neuronal death.
Discussion
We found increased levels of NP1 protein in the CM
from OGD-exposed WT primary cortical neuronal cul-
tures, and this CM caused substantial neurotoxicity
when added to control cortical cultures. Most strikingly,
the CM from OGD-exposed NP1-KO cortical cultures
did not induce neurotoxicity to normal cortical cultures
under identical conditions, and that NP1-KO cells main-
tained characteristic features of healthy neuronal morph-
ology with intact processes. First, we found induction of
NP1 following OGD exposure of cortical neurons and
neuronal death, whereas, inhibition of NP1 expression
by NP1-specific siRNA exerts neuroprotection against
OGD. Our findings suggest that NP1, being a secretory
protein, after induction following OGD undergoes re-
lease from neurons and this extracellular NP1 is in-
volved in ischemic neuronal death. Here, we present
evidence that extracellular secretion of NP1 proteinfollowing exposure to OGD is necessary to induce ische-
mic neuronal death, suggesting a new extracellular pro-
death function of NP1.
Previously we have reported a role for NP1 in neonatal
hypoxic-ischemic brain injury and subcellular localization
of NP1 in to mitochondria enhanced mitochondria-
mediated neuronal death [6-8]. We also reported interac-
tions of NP1with excitatory AMPA GluR1 receptors and
direct regulation of surface GluR1 expression and synaptic
clustering of NP1 with GluR1 [22]. These findings suggest
the possibility that presynaptic NPR which binds to NP1;
allowing NP1 to trans-synaptically attach to the extracellu-
lar domain of GluR1 at the postsynaptic specialization,
thereby facilitating glutamate binding and, thus, enhancing
excitotoxicity. In contrast, NP1-KO neurons showed re-
duced cytotoxicity by limiting synaptic GluR1 cluster for-
mation due to absence of extracellular NP1 at synaptic
sites. We also found that this clustering activity involves
physical association between NP1 and GluR1, and that
NP1 exhibited profound synaptic co-clustering with GluR1
following OGD [22]. Thus, it is possible that extracellular
NP1 may disrupt inter-neuronal synaptic activity, which
possibly contributes to the neuronal death in hypoxic-
ischemic brain injury via clustering with GluR1.
Based on cDNA sequence, NP1 is predicted to be se-
creted protein [9], raising the possibility that it is present
on the neuronal surface that enhances the toxicity of neur-
onal cells under hypoxic-ischemic stress. We performed a
series of experiments to evaluate the importance of extra-
cellular NP1 in hypoxic-ischemic neuronal death. Hypoxic-
WT cells + WT-con CM WT cells +WT-OGD CM
NP1-KO cells+WT-con CM NP1-KO cells+WT-OGD CM







Figure 5 Absence of NP1 protein in NP1-KO OGD conditioned medium does not cause neuronal death in WT normoxia cortical
cultures. Morphological evidence of degenerated cell bodies and processes reveal that WT OGD CM induced neuronal degeneration in control
WT cultures (A-A1) whereas, OGD conditioned NP1-KO CM did not cause cell death in WT cultures (B-B1). In contrast, NP1-KO cortical cultures,
which are protected against OGD, showed neuronal death when treated with WT-OGD CM (C-C1). Representative light microscopic images are
shown, n = 6, Scale, 100 μm.
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Figure 6 NP2-KO OGD conditioned medium caused neurotoxicity and death in WT normoxia cortical cultures. Quantification of cell
death by LDH release assay revealed significantly higher percentage of cell death when WT-OGD CM was added to WT control cultures (A).
B) The NP2-KO OGD CM caused similar extent of cytotoxicity when added to the WT control cultures as compared to control CM (Con-CM).
Similarly, the NP2-KO OGD CM in combination with OGD further enhanced cell death. Data shown are mean ? SEM (n = 8 in each group) and
repeated two times, **p < 0.01 vs. normoxia controls. C) Western blot analysis of OGD exposed NP2-KO CM showed OGD time-dependent
increased levels of NP1 protein present in the NP2-KO OGD CM, suggesting NP1, but not the NP1, contributes to neuronal death. Representative
bands are shown.
Cortical neurons












Figure 7 Extracellular release of NP1 protein following OGD enhances interaction between NP1 and GluR1 at the synaptic sites.
Live immunostaining of DIV 12 primary cortical neurons with NP1 and GluR1 antibodies following OGD (4 h). Immunofluorescence microscopy
and merged images show increased number of NP1 (red) and GluR1 (green) co-localized clusters (yellow) at cortical dendrites and axons.
Representative images are shown, n = 6, Scale, 100 μm.
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glutamatergic excitotoxicity cascade [32] and several down-
stream cytotoxic pathways [1,33]. It appear from our
present findings that NP1 is induced and released following
OGD and recruited to surface GluR1 subunits to form
clusters at excitatory synapses, and increased NP1-GluR1
interactions sensitize neurons to OGD- induced neuronal
death. These members of the long-pentraxin family, NP1
and NP2, are exclusively expressed in the central neurons
and are secretory from cells upon pathological stress. To
further delineate the role of secretory NPs in neuronal
death, we found that it is NP1 protein, not the NP2, is in-
volved in neuronal death as evident by our findings that
the CM from the OGD-exposed NP2-KO cortical cultures
caused neuronal death when added to the normal cortical
cultures similar to that induced by WT-OGD CM. The
role of NP1 in neuronal death is also evidenced by the
presence of increased amount of NP1 protein in the NP2-
KO CM that caused neurotoxicity.
Conclusions
Collectively, our results argue that extracellular secretion
of NP1 following OGD provides a mechanism that poten-
tiates ischemic neuronal death possibly via AMPA GluR1-
mediated function at the excitatory synapses, and that
NP1, not its family member NP2, is involved in neuronal
death mechanisms. Our results suggest NP1 as a practical
target for preventing ischemic neuronal death.
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